Cataract surgery in the highly myopic patient, typically defined by an axial length greater than 26 mm, represents one of the most demanding scenarios in refractive cataract surgery.While these patients often have the most to gain in terms of visual qu…
VIDEO: Real-world data on aflibercept 8 mg expected in 2026
WAIKOLOA, Hawaii — In this expert perspective from Retina 2026, Murtaza K. Adam, MD, of Colorado Retina Associates, discusses real-world data coming in 2026.He said he is excited about data on Eylea HD (aflibercept 8 mg, Regeneron).Adam said there is a…
Early Retinal Fluid Drying May Extend Injection Gaps in AMD
Rapid drying of retinal fluid with faricimab injections may help identify patients with neovascular age-related macular degeneration who can safely extend time between injections. Medscape Medical News
White House picks NIH director Bhattacharya to run CDC for now
NIH Director Jay Bhattacharya, MD, PhD, has been picked to also serve as acting director of the CDC, a White House official confirmed to Healio.Bhattacharya will oversee both agencies until a permanent CDC director is nominated and confirmed, the offic…
FDA expands age indication for EVO ICL
Editor’s note: This is a developing news story. Please check back soon for updates.The FDA approved an expanded age indication for the EVO/EVO+ Visian Implantable Collamer Lens in the U.S.Previously approved for patients between the ages of 21 to 45 ye…
NexEos Bio Announces FDA Clearance of IND Application to Proceed to Phase II/III Trial of NTX-1024 in Vernal Keratoconjunctivitis
MALVERN, Pa.–(BUSINESS WIRE)–NexEos Bio Vision Health (“NexEos”), a clinical-stage biopharmaceutical company developing novel therapies and diagnostics targeting eosinophil-mediated diseases, today announced that the U.S. Food and Drug Administration…